Alison Moore's Net Worth
$11 Million
Who is Alison Moore?
Alison Moore has an estimated net worth of $11 Million. This is based on reported shares across multiple companies, which include CODEXIS, INC., and Allogene Therapeutics, Inc..
SEC CIK
Alison Moore's CIK is 0001754937
Past Insider Trading and Trends
2019 was Alison Moore's most active year for acquiring shares with 10 total transactions. Alison Moore's most active month to acquire stocks was the month of February. 2019 was Alison Moore's most active year for disposing of shares, totalling 16 transactions. Alison Moore's most active month to dispose stocks was the month of September. 2019 saw Alison Moore paying a total of $395,656.46 for 294,848 shares, this is the most they've acquired in one year. In 2020 Alison Moore cashed out on 266,405 shares for a total of $5,163,562.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CODEXIS, INC. (CDXS) Snapshot price: $2.74
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +43.92% | 30.12K |
—
|
—
| 98.7K |
Jun 11
| |||
Form 4
| +101.85% | 34.6K |
—
|
—
| 68.58K |
Jun 13
| |||
Form 4
| +49.66% | 11.27K |
—
|
—
| 33.97K |
Jun 14
| |||
Form 4
| +26.79% | 4.8K |
—
|
—
| 22.7K |
Jun 15
| |||
Form 4
|
∞
| 17.91K |
—
|
—
| 17.91K |
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Allogene Therapeutics, Inc. (ALLO) Snapshot price: $2.39
Chief Technical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +486.84% | 558.09K |
—
|
—
| 672.73K |
Mar 22
| |||
Form 4
| -6.79% | -8.35K |
$5.51 | -$45,989.79 | 114.64K |
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
| -6.74% | -8.70K |
$7.63 | -$66,388.35 | 120.43K |
Mar 15
| |||
Form 4
| +24.24% | 24.87K |
—
|
—
| 127.44K |
Mar 26
| |||
Form 4
| -5.67% | -6.16K |
$38.14 | -$235,089.41 | 102.57K |
Mar 15
| |||
Form 4
|
—
|
0
|
$22.14 | -$1,401,038.72 | 108.37K |
Scheduled
|
Oct 12 - Oct 13
| ||
Form 4
| -7.91% | -9.31K |
$21.64 | -$1,747,484.72 | 108.37K |
Scheduled
|
Oct 8 - Oct 9
| ||
Form 4
| -3.23% | -9.31K |
$21.14 | -$1,702,910.72 | 279.22K |
Scheduled
|
Oct 6
| ||
Form 4
| +34.59% | 32.45K |
$2.27 | $73,663.77 | 126.27K |
Aug 13
| |||
Form 4
| +48.87% | 30.8K |
—
|
—
| 93.82K |
Mar 18
| |||
Form 4
| -5.62% | -3.75K |
$19.19 | -$71,980.12 | 63.02K |
Mar 16
| |||
Form 4
|
—
|
0
|
$17.19 | -$1,456,828.95 | 66.07K |
Scheduled
|
Sep 16 - Sep 18
| ||
Form 4
|
—
|
0
|
$15.86 | -$1,326,765.39 | 65.37K |
Scheduled
|
Jul 26 - Jul 30
| ||
Form 4
| +74.06% | 27.82K |
$2.27 | $63,142.32 | 65.37K |
Jun 28
| |||
Form 4
|
—
|
0
|
$14.52 | -$1,195,934.78 | 37.56K |
Scheduled
|
Jun 3
| ||
Form 4
|
∞
| 37.05K |
—
|
—
| 37.05K |
Mar 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Artiva Biotherapeutics, Inc. (ARTV) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||